Can somebody clarify this. To me the multiples paid seem a little bit higher than they say...
So if look at podiatry and take the 77.8% equity stake that HLA has in the company and we look 77.8% ownership of the EBITDA then we get...
Podiatry (1,026*0.778=$798k)
That makes the multiple paid (assuming earnout is paid):
Podiatry (3785+200)/798 = 4.99x
Or does HLA actually require payment for clinic class shares from the vendor? i.e. they will have the right to repurchase those shares off the vendor when/if they leave?
- Forums
- ASX - By Stock
- HLA
- Ann: FY2019 Full Year Results - Media Release
Ann: FY2019 Full Year Results - Media Release, page-9
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online